Oncology & Cancer

AACR: LY2835219 promising for metastatic breast cancer

(HealthDay)—The novel cell cycle inhibitor selective for the cyclin-dependent kinases CDK4 and CDK6 (CDK4/6), LY2835219, shows promise for metastatic breast cancer, according to a study presented at the annual meeting of ...

Oncology & Cancer

Obesity and diabetes have adverse effects on cancer outcomes

Both obesity and diabetes have adverse effects on outcomes in breast cancer patients who receive chemotherapy as primary treatment before surgery (neoadjuvant chemotherapy), according to research to be presented at the 9th ...

Oncology & Cancer

New breast cancer stem cell findings explain how cancer spreads

Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to an international collaboration of researchers. Their finding sheds new light on the process that makes ...

Oncology & Cancer

Rock And Rho: Proteins that help cancer cells groove

Biologists at The Johns Hopkins University have discovered that low oxygen conditions, which often persist inside tumors, are sufficient to initiate a molecular chain of events that transforms breast cancer cells from being ...

page 27 from 30